IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I7A157

Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents

Kenichi Komukai, MD; Chiara Bernelli, MD; Vasile Sirbu, MD; Giulio Guagliumi*, MD

A 77-year-old man was admitted to our institution with a lateral ST-segment elevation myocardial infarction. Two years earlier, a paclitaxel-eluting stent (PES) and an everolimus-eluting stent (EES) had been implanted separately in the left circumflex coronary artery. Clopidogrel was discontinued after 12 months; aspirin was maintained indefinitely. Coronary angiography proved definite stent thrombosis (ST). After manual thrombus aspiration restenosis involving both stents was observed (Figure 1A). Optical coherence tomography (OCT) detected in-stent heterogeneous, low-intensity and attenuated neointima (Figure 1B, Figure 1C, Figure 1F, Figure 1G, Moving image 1, Moving image 2) compared with the homogeneous, high-intensity signal of adjacent fibrous tissue (Figure 1D, Figure 1E). After balloon angioplasty, the in-stent “sponge-like” pattern changed to a thin-layer neointima, similar to the signal from the interposed vessel segment (Appendix Figure 1, Appendix Figure 2).

Figure 1. Angiography and OCT after manual thrombus aspiration. Severe in-stent restenosis was observed in the PES and EES (A, dotted lines). OCT demonstrated heterogeneous, signal-poor and attenuated neointima in both stents (B, C and F, G) compared to a homogeneous and intense signal in-between (D, E). Rich neovascularisation was detected within neointima (B, C, arrowheads).

Atherosclerotic changes of the neointima may act as a causative factor for late ST. The present case demonstrates that neoatherosclerosis (NA) can occur also in newer-generation drug-eluting stents. The high lipid content and the soft tissue characterising NA make a balloon angioplasty a possible therapeutic option to avoid multilayered stent implantation.

Conflict of interest statement

G. Guagliumi and V. Sirbu received consulting/grant support from St. Jude Medical. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. OCT pullback pre balloon angioplasty focused on EES. OCT pullback shows characteristics of the EES neoatherosclerosis.

Moving image 2. OCT pullback pre balloon angioplasty focused on PES. OCT pullback shows characteristics of the PES neoatherosclerosis.

Supplementary data

To read the full content of this article, please download the PDF.

OCT pullback pre balloon angioplasty focused on EES. OCT pullback shows characteristics of the EES neoatherosclerosis.

Moving image 2. OCT pullback pre balloon angioplasty focused on PES. OCT pullback shows characteristics of the PES neoatherosclerosis.

Volume 11 Number 7
Nov 20, 2015
Volume 11 Number 7
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV12I10A201 Nov 20, 2016
Ruptured “non-culprit” in-stent neoatherosclerosis during ST-segment elevation acute myocardial infarction
Cuesta J et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV10I12A251 Apr 20, 2015
Very late stent thrombosis caused by neoatherosclerotic plaque rupture
Hougaard M et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00486 Dec 20, 2018
Prevalence of neoatherosclerosis in sirolimus-eluting stents in a very late phase after implantation
Usui E et al
free

Image – Interventional flashlight

10.4244/EIJ-D-20-00507 Aug 6, 2021
Optical coherence tomography and tailored treatment of in-stent restenosis
Jia H et al
free
Trending articles
334.45

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
43.05

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
32.7

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
28.85

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
28.85

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved